Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genetics Pharmaceuticals is a leading pharmaceutical company based in Lahore, Pakistan, with a specialized focus on Central Nervous System (CNS) therapeutics. Since its inception in 2005, the company has established itself as a significant player in the psychiatry and neurology segments, providing a wide range of branded generic medications for disorders such as depression, schizophrenia, and epilepsy. Beyond its core CNS portfolio, the company manufactures products for cardiology, gastroenterology, and infectious diseases. Genetics Pharmaceuticals operates state-of-the-art, cGMP-compliant manufacturing facilities and maintains an active presence in both the domestic Pakistani market and various international export markets. The company's mission centers on delivering high-quality, affordable healthcare solutions through continuous innovation in formulation and manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genetics Pharmaceuticals.